Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast Cancer

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced results of its collaborative study on universal hereditary cancer...

Related Keywords

North Carolina ,United States ,Linkedin Invitae ,Robert Nussbaum ,Charles Shelton ,National Comprehensive Cancer Network ,Exchange Commission ,Invitae Corporation ,Outer Banks Hospital ,Private Securities Litigation Reform Act ,Quarterly Report ,